| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $70.8M | -11.9% | -48.9% |
| R&D Expense | $3.2M | +8.0% | +1.5% |
| SG&A Expense | $30.1M | -3.7% | +4.5% |
| Operating Income | -$42.0M | -140.1% | -514.1% |
| Pre-tax Income | -$43.2M | -140.9% | -577.8% |
| Income Tax | -$13.5M | -192.0% | -401.0% |
| Net Income | -$27.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $73.4M | -29.6% | -18.0% |
| Accounts Receivable | $107.0M | -12.8% | -54.2% |
| Current Assets | $190.2M | -19.6% | -42.1% |
| Total Assets | $353.8M | -13.3% | -28.4% |
| Current Liabilities | $73.6M | -26.5% | -51.0% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $44.9M | — | — |
| Capital Expenditures | $3.0M | — | — |
| Investing Cash Flow | -$26.0M | — | — |
| Financing Cash Flow | -$49.0M | — | — |
| Free Cash Flow | $41.9M | — | — |
| -148.9% |
| -605.1% |
| EPS (Basic) | -$0.28 | -154.5% | -660.0% |
| EPS (Diluted) | -$0.28 | -154.5% | -660.0% |
| $250K |
| +1884.5% |
| +423.8% |
| Total Liabilities | $93.1M | -22.7% | -44.9% |
| Stockholders' Equity | $270.5M | -9.0% | -16.8% |